Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8785442
APP PUB NO 20140031353A1
SERIAL NO

13982456

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound as antagonist of LPA receptor, and a pharmaceutical composition comprising the same. The present invention also relates to the use of the compound and the composition, and a method of using the compound to treat, prevent or diagnose diseases, disorders or conditions associated with one or more of the LPA receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CUREGENIX INCBUILDING D FLOOR 10 INTERNATIONAL BUSINESS INCUBATOR GUANGZHOU SCIENCE CITY GUANGZHOU 510663

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
An, Songzhu Guangzhou, CN 23 77
Huang, Chen Guangzhou, CN 93 438
Li, Chufang Guangzhou, CN 3 28
Zhou, Guisheng Guangzhou, CN 5 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 22, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00